BioWorld

April 11, 2011

Parkinson's Update: Disease Pipeline Running the Gamut

There were roughly 40 million Americans over the age of 65 in 2010, but as the baby boomer generation continues to reach the monumental age, the number of Americans in that class is expected to increase to 70 million in 2030. Read More

A Mega-Merger About-Face as Industry Retools R&D Strategy

Money Raised Year to Date

Money Raised By Biotech in 2011

Week in Review

Week in Washington

Word on the Street

Top 10 Bio/Pharma Deals This Year

Collaborations Between Biotech And Pharmaceutical Companies: Jan. 1 - Apr. 8, 2011

Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Jan. 1 - Apr. 8, 2011

Biotech – Big Pharma Collaborations: Modified And Terminated Agreements, Jan. 1 - Apr. 8, 2011

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

No Abstract Read More

Today's news in brief

BioWorld

BioWorld briefs for July 20, 2026.

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

Capital remains selective in ‘barbell’ biotech market

BioWorld

Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...

Elderly hands holding broken brain structure

Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

BioWorld Science

Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...

LIT-002 is strong candidate for autism and neuropathic pain

BioWorld Science

Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...